Literature DB >> 928270

Clinical pharmacokinetics of atenolol.

J McAinsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 928270

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  21 in total

1.  The effect of infinitesimal drug dilutions on the pharmacokinetics of nalidixic acid and atenolol.

Authors:  N Ferry; N Bernard; N Pozet; E Gardes; M Bruguier; G Cuisinaud; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

2.  Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).

Authors:  R A Vukovich; J E Foley; B Brown; D A Willard; M Buckley; D O'Kelly; D Fitzgerald; W Tormey; A Darragh
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Modulation of the effects of salbutamol by propranolol and atenolol.

Authors:  N A Minton; A R Baird; J A Henry
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

5.  β-Blocker Dialyzability in Maintenance Hemodialysis Patients: A Randomized Clinical Trial.

Authors:  Alvin Tieu; Thomas J Velenosi; Andrew S Kucey; Matthew A Weir; Bradley L Urquhart
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 8.237

6.  The influence of renal function on clinical pharmacokinetics of moxonidine.

Authors:  W Kirch; H J Hutt; V Plänitz
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

7.  Pharmacokinetics of atenolol in relation to renal function.

Authors:  W Kirch; H Köhler; E Mutschler; M Schäfer
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

8.  Pharmacokinetics of oral timolol studied by mass fragmentography.

Authors:  J B Fourtillan; P Courtois; M A Lefebvre; J Girault
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

9.  Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone.

Authors:  E Riva; P L Farina; R Sega; G Tognoni; W Bastain; J McAinsh
Journal:  Eur J Clin Pharmacol       Date:  1980-05       Impact factor: 2.953

10.  Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.

Authors:  R G Wilcox; J R Hampton
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.